| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Soft Tissue Tumor Unit, Department of Histopathology, U.M.D.S. St. Thomas' Hospital, London SE1 7EH, United Kingdom [J. C. K., P. J. R., C. D. M. F.], and Center for Human Genetics, University of Leuven, B-3000 Leuven, Belgium [P. D. C., H. V. D. B.]
Translocation t(12;16)(q13;p11) is regarded as a diagnostic marker for myxoid liposarcoma. Cytogenetic data on round cell liposarcomas and combined myxoid and round cell tumors is scarce, and the genetic basis of progression of myxoid tumors to high grade, round cell lesions is unknown. We have accumulated six round cell, four combined myxoid and round cell, and three myxoid liposarcomas for analysis. t(12;16)(q13;p11) was present in three round cell lesions and was detectable in all of the tumors by DNA analysis. In each tumor type, the CHOP gene in 12q13 was rearranged and fused to the TLS gene in 16p11. A variant TLS-CHOP RNA transcript was detected by polymerase chain reaction but did not correlate with clinicopathological data. No distinguishing cytogenetic or molecular markers for round cell or mixed lesions were found. The histogenic and genetic relatedness of myxoid and round cell liposarcomas is apparent from these data.
1 Supported by the John Ellerman Foundation and the Special Trustees of St. Thomas' Hospital, London (to J. C. K. and P. J. R.), the Belgian Programme on Inter-University Poles of Attraction initiated by the Belgian State Prime Minister's Office, Science Policy Programming (to P. D. C.), and EEC Biomed 1 program "Molecular Cytogenetics of Solid Tumors" (to P. D. C., C. D. M. F., and J. C. K.).
2 To whom requests for reprints should be addressed.
Received 9/22/94. Accepted 11/14/94.
This article has been cited by other articles:
![]() |
P. A. Perez-Mancera, C. Vicente-Duenas, I. Gonzalez-Herrero, M. Sanchez-Martin, T. Flores-Corral, and I. Sanchez-Garcia Fat-specific FUS-DDIT3-transgenic mice establish PPAR{gamma} inactivation is required to liposarcoma development Carcinogenesis, October 1, 2007; 28(10): 2069 - 2073. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Costa, M. G. Daidone, L. Daprai, R. Villa, S. Cantu, S. Pilotti, L. Mariani, A. Gronchi, J. D. Henson, R. R. Reddel, et al. Telomere Maintenance Mechanisms in Liposarcomas: Association with Histologic Subtypes and Disease Progression. Cancer Res., September 1, 2006; 66(17): 8918 - 8924. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Murphey, L. K. Arcara, and J. Fanburg-Smith From the Archives of the AFIP: Imaging of Musculoskeletal Liposarcoma with Radiologic-Pathologic Correlation RadioGraphics, September 1, 2005; 25(5): 1371 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Johnson, R. J. Varkonyi, J. Schwalm, R. Cragle, A. Klein-Szanto, A. Patchefsky, E. Cukierman, M. von Mehren, and D. Broccoli Multiple Mechanisms of Telomere Maintenance Exist in Liposarcomas Clin. Cancer Res., August 1, 2005; 11(15): 5347 - 5355. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Tateishi, T. Hasegawa, Y. Beppu, A. Kawai, M. Satake, and N. Moriyama Prognostic Significance of MRI Findings in Patients with Myxoid-Round Cell Liposarcoma Am. J. Roentgenol., March 1, 2004; 182(3): 725 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
U Tateishi, T Hasegawa, Y Beppu, A Kawai, and N Moriyama Prognostic significance of grading (MIB-1 system) in patients with myxoid liposarcoma J. Clin. Pathol., August 1, 2003; 56(8): 579 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hosaka, Y. Nakashima, K. Kusuzaki, H. Murata, T. Nakayama, T. Nakamata, T. Aoyama, T. Okamoto, K. Nishijo, N. Araki, et al. A Novel Type of EWS-CHOP Fusion Gene in Two Cases of Myxoid Liposarcoma J. Mol. Diagn., August 1, 2002; 4(3): 164 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Antonescu, S. J. Tschernyavsky, R. Decuseara, D. H. Leung, J. M. Woodruff, M. F. Brennan, J. A. Bridge, J. R. Neff, J. R. Goldblum, and M. Ladanyi Prognostic Impact of P53 Status, TLS-CHOP Fusion Transcript Structure, and Histological Grade in Myxoid Liposarcoma: A Molecular and Clinicopathologic Study of 82 Cases Clin. Cancer Res., December 1, 2001; 7(12): 3977 - 3987. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Oliveira, A. G. Nascimento, S. H. Okuno, and R. V. Lloyd p27kip1 Protein Expression Correlates With Survival in Myxoid and Round-Cell Liposarcoma J. Clin. Oncol., August 15, 2000; 18(15): 2888 - 2893. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Antonescu, A. Elahi, M. Humphrey, M. Y. Lui, J. H. Healey, M. F. Brennan, J. M. Woodruff, S. C. Jhanwar, and M. Ladanyi Specificity of TLS-CHOP Rearrangement for Classic Myxoid/Round Cell Liposarcoma: Absence in Predominantly Myxoid Well-Differentiated Liposarcomas J. Mol. Diagn., August 1, 2000; 2(3): 132 - 138. [Abstract] [Full Text] |
||||
![]() |
C. R. Antonescu, A. Elahi, J. H. Healey, M. F. Brennan, M. Y. Lui, J. Lewis, S. C. Jhanwar, J. M. Woodruff, and M. Ladanyi Monoclonality of Multifocal Myxoid Liposarcoma: Confirmation by Analysis of TLS-CHOP or EWS-CHOP Rearrangements Clin. Cancer Res., July 1, 2000; 6(7): 2788 - 2793. [Abstract] [Full Text] |
||||
![]() |
M. Kuroda, X. Wang, J. Sok, Y. Yin, P. Chung, J. W. Giannotti, K. A. Jacobs, L. J. Fitz, P. Murtha-Riel, K. J. Turner, et al. Induction of a secreted protein by the myxoid liposarcoma oncogene PNAS, April 27, 1999; 96(9): 5025 - 5030. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Demetri, C. D. M. Fletcher, E. Mueller, P. Sarraf, R. Naujoks, N. Campbell, B. M. Spiegelman, and S. Singer Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma PNAS, March 30, 1999; 96(7): 3951 - 3956. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tontonoz, S. Singer, B. M. Forman, P. Sarraf, J. A. Fletcher, C. D. M. Fletcher, R. P. Brun, E. Mueller, S. Altiok, H. Oppenheim, et al. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor PNAS, January 7, 1997; 94(1): 237 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gisselsson, L. Pettersson, M. Hoglund, M. Heidenblad, L. Gorunova, J. Wiegant, F. Mertens, P. Dal Cin, F. Mitelman, and N. Mandahl Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity PNAS, May 9, 2000; 97(10): 5357 - 5362. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |